Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Conbercept for Idiopathic Choroidal Neovascularization
NCT02857517Phase 2Unknown
- Start
- Jun 2016
- Primary completion
- Jun 2018
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of conbercept in choroidal neovascularization (CNV). Status: unknown.
02
Drugs
conbercept
03
Conditions
choroidal neovascularization (CNV)
Beyond the preview
Go deeper on NCT02857517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02857517.